Today the US Preventive Services Task Force — an advisory panel of cancer experts — released a new recommendation that men should no longer routinely undergo a PSA blood test to screen for prostate cancer. The federally appointed panel concluded that the harms of unnecessary surgeries or other interventions outweigh the benefits of the test.
The Task Force released the recommendation in today’s issue of the journal Annals of Internal Medicine.
The American Urological Society is one organization saying the Task Force is taking an extreme position, and that regular PSA screening for men 50 and over saves lives.
While the back-and-forth continues, we at AICR believe that the decision of how often to screen for this and other cancers remains a personal one, and one that is best decided in consultation with one’s healthcare provider. Continue reading